Respiratory Aspiration

Breathing in liquid or solids, such as stomach contents, into the RESPIRATORY TRACT. When this causes severe lung damage, it is called ASPIRATION PNEUMONIA.
Also Known As:
Aspiration, Respiratory; Respiratory Aspiration of Gastric Contents; Aspiration of Gastric Contents
Networked: 122 relevant articles (6 outcomes, 14 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Pneumonia (Pneumonitis)
2. Wounds and Injuries (Trauma)
3. Contusions
4. Sepsis (Septicemia)
5. Heart Arrest (Cardiac Arrest)


1. Zhang, Mao: 5 articles (09/2012 - 05/2008)
2. Sheng, Lei: 4 articles (09/2012 - 05/2008)
3. Gan, Jianxin: 2 articles (09/2012 - 05/2008)
4. Wu, Junsong: 2 articles (09/2012 - 05/2008)
5. Xu, Shaowen: 2 articles (09/2012 - 05/2008)
6. Ma, Yue-feng: 2 articles (06/2009 - 06/2008)
7. Xu, Shao-wen: 2 articles (06/2009 - 06/2008)
8. Jiang, Guan-yu: 2 articles (06/2009 - 06/2008)
9. Wu, Jun-song: 2 articles (06/2009 - 06/2008)
10. Gu, Jun: 2 articles (03/2009 - 05/2008)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Respiratory Aspiration:
1. Anti-Bacterial Agents (Antibiotics)IBA
06/01/2007 - "Univariate analysis identified the following factors: decreased level of consciousness, craniotomy, prior use of antibiotics, mechanical ventilation, nasogastric tube feeding, enteral feeding, aspiration of gastric contents, central venous catheter and the time spent in the ICU. "
09/01/1998 - "6, Regarding the risk factors for VAP, factors such as the duration of mechanical ventilation, the existence of chronic obstructive pulmonary disease, a hyponutritional state, prior antibiotics, aspiration of gastric contents, histamine-type-2 receptor antagonist, and multiple organ failure showed significant differences and were suspected to be associated with the appearance of VAP."
01/01/1978 - "The management of the aspiration of gastric contents is considered under five different headings - clearance of the airway, the problem of oxygenation, the use of steroids, the possible use of prophylactic antibiotics and the general measures applicable to the care of any seriously ill patient. "
01/01/2003 - "VAP was observed 2.3 years after the initiation of mechanical ventilation with significant differences in the following risk factors being observed between VAP (+) and VAP (-) groups: chronic obstructive pulmonary disease, duration of mechanical ventilation, prior antibiotics, aspiration of gastric contents and use of histamine-type II receptor antagonist. "
01/01/2010 - "We also found differences related to age: younger infants showed an increased risk of admission, clinical differences (greater presence of rhinitis, vomiting, refusal of feedings, apnea and septic appearance and less fever and night cough; more tachypnea, retractions, hypoventilation and impaired consciousness, and lower presence of wheezing), increased number of diagnostic tests (oxygen saturation, chest x-ray, RSV test, CBC, etc.) and differences in patterns of treatment (less use of all medications before diagnosis and the maintenance phase; in the acute phase, increased use of epinephrine and parenteral corticosteroids and lower use of bronchodilators and oral corticosteroids, and more frequent use of supplemental oxygen, intravenous fluids, intravenous antibiotics, nasal washings, respiratory aspiration, chest physiotherapy, assisted ventilation and heliox). "
2. SteroidsIBA
3. rabeprazole (Aciphex)FDA Link
4. Omeprazole (Esomeprazole)FDA LinkGeneric
5. Biological Markers (Surrogate Marker)IBA
6. Metoclopramide (Reglan)FDA LinkGeneric
7. Adrenal Cortex Hormones (Corticosteroids)IBA
8. Proton Pumps (Proton Pump)IBA
9. Pepsin A (Pepsin)IBA
10. OxygenIBA

Therapies and Procedures

1. Anesthesia
2. Positive-Pressure Respiration (PEEP)
3. Laryngectomy
4. General Anesthesia
5. Enteral Nutrition (Feeding, Tube)